Clinical Trial Update: A Dose Response Trial to Evaluate Clinical and Mycological Effect of Nitric Oxide in Subjects With Tinea Pedis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the clinical and mycological effects of nitric oxide in subjects with tinea pedis; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tinea Pedis

Drugs mentioned

• Nitric Oxide (nitric oxide)

Snippet

Sponsor: Nitric BioTherapeutics, Inc | Conditions: Tinea Pedis | Phase 2 | Status: COMPLETED